Drugmakers’ leading industry group is the latest to file a lawsuit seeking to stop Medicare’s newly granted power to negotiate drug prices. The Pharmaceutical Research and Manufacturers of America, known as PhRMA, argues that the negotiation provision is unconstitutional.